Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARCK

Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis

Arbor Rapha Capital Bioholdings Corp. I logo

About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK)

Advanced Chart

Key Stats

Today's Range
$11.90
$11.90
50-Day Range
$10.42
$15.41
52-Week Range
$9.93
$15.59
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARCK Stock News Headlines

DRGV Dragon Capital Group, Corp.
ECN Capital Corp. (ECNCF)
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
SuRo Capital Corp.
Ready Capital Corp.
Oxford Lane Capital Corp. (OXLC)
Deal Pro Capital Corporation (DPCC-P.V)
Quad 7 Capital
See More Headlines

ARCK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI).

Company Calendar

Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
UNCLASSIFIED
Sub-Industry
N/A
Current Symbol
NASDAQ:ARCK
CIK
1452872
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ARCK) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners